We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $572.75 in the latest trading session, marking a -2.3% move from the prior day. This change lagged the S&P 500's daily gain of 0.16%. On the other hand, the Dow registered a gain of 0.17%, and the technology-centric Nasdaq increased by 0.26%.
Coming into today, shares of the company had gained 8.1% in the past month. In that same time, the Medical sector gained 2.84%, while the S&P 500 gained 1.89%.
Market participants will be closely following the financial results of Intuitive Surgical, Inc. in its upcoming release. The company plans to announce its earnings on January 22, 2026. In that report, analysts expect Intuitive Surgical, Inc. to post earnings of $2.25 per share. This would mark year-over-year growth of 1.81%. At the same time, our most recent consensus estimate is projecting a revenue of $2.72 billion, reflecting a 12.59% rise from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $8.65 per share and a revenue of $9.92 billion, indicating changes of +17.85% and 0%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that Intuitive Surgical, Inc. has a Forward P/E ratio of 61 right now. This denotes a premium relative to the industry average Forward P/E of 24.15.
We can also see that ISRG currently has a PEG ratio of 3.88. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.24.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $572.75 in the latest trading session, marking a -2.3% move from the prior day. This change lagged the S&P 500's daily gain of 0.16%. On the other hand, the Dow registered a gain of 0.17%, and the technology-centric Nasdaq increased by 0.26%.
Coming into today, shares of the company had gained 8.1% in the past month. In that same time, the Medical sector gained 2.84%, while the S&P 500 gained 1.89%.
Market participants will be closely following the financial results of Intuitive Surgical, Inc. in its upcoming release. The company plans to announce its earnings on January 22, 2026. In that report, analysts expect Intuitive Surgical, Inc. to post earnings of $2.25 per share. This would mark year-over-year growth of 1.81%. At the same time, our most recent consensus estimate is projecting a revenue of $2.72 billion, reflecting a 12.59% rise from the equivalent quarter last year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $8.65 per share and a revenue of $9.92 billion, indicating changes of +17.85% and 0%, respectively, from the former year.
Investors should also pay attention to any latest changes in analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #2 (Buy).
Valuation is also important, so investors should note that Intuitive Surgical, Inc. has a Forward P/E ratio of 61 right now. This denotes a premium relative to the industry average Forward P/E of 24.15.
We can also see that ISRG currently has a PEG ratio of 3.88. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.24.
The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 99, finds itself in the top 41% echelons of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.